Metabolomics enabled the identification of pre-frailty sub-phenotypes in elderly

International audience; Context: Ageing is a dynamic process depending on intrinsic and extrinsic factors and its evolution is a continuum of transitions, involving multifaceted processes at multiple levels. It is recognized that frailty and sarcopenia are shared by the major age-related diseases thus contributing to elderly morbidity and mortality. They are major health issues in aging populations, given their high prevalence and association with several adverse outcomes. Pre-frailty is still not well understood but it has been associated with changes in several physiological systems, including inflammation as well as changes in the balance of micronutrients and vitamins. Due to the complex phenotypes and underlying pathophysiology, the need for robust and multidimensional biomarkers is now essential to move towards more personalized care and prevention. Objective: The objective of the present study was to better characterize the complexity of pre-frailty phenotype using untargeted metabolomics in order to identify specific biomarkers, and study their stability over time. Research design and methods: The approach was based on the NU-AGE project (FP7 EU programme; clinicaltrials.gov, NCT01754012) that regrouped 1,250 free-living elderly people (65-79 y.o., men and women), free of major diseases, recruited within five European centres. Half of the volunteers were randomly assigned to an intervention group (1-year Mediterranean type diet). Presence of frailty was assessed by the criteria proposed by Fried et al (Fried et al. J Gerontol A Biol Sci Med Sci, 2001). In this study, a sub-cohort consisting in 212 subjects (pre-frail and non-frail) from the Italian and Polish centres were selected for mass spectrometry-based untargeted metabolomics. Metabolic profiles were determined from serum samples at T0 (baseline) and T1 (follow-up). All data were processed under the Galaxy web-based platform Worflow4metabolomics, guaranteeing their reproducibility (Giacomoni et al. Bioinformatics, 2015). Univariate statistical analyses were performed to identify discriminant metabolites regarding pre-frailty status. Predictive models were then built using linear logistic regression and ROC curve analyses were used to evaluate multivariate biomarkers. Results: Presence of sub-phenotypes of pre-frailty both at the gender level and depending on the pre-frailty progression and reversibility were revealed by untargeted metabolomics. Additionally, early markers, able to predict the evolution towards pre-frailty within one year, were identified for both genders. Moreover, some of these early biomarkers were found to be still relevant for classification of a ‘light pre-frail’ phenotype after its clinical appearance. Conclusion: These results open the door, through multivariate strategies, to the possibility of monitoring the disease progression over time at a very early stage. Longitudinal analysis of individual time trajectories to detect early deviations of health status would indeed contribute to a better disease prevention.